Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Jun 2024 for KALA BIO, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Mark S. Blumenkranz: trading record in brief
Mark S. Blumenkranz, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in IVERIC bio, Inc., KALA BIO, Inc. and 1Life Healthcare Inc. Between 15 July 2021 and 11 June 2024, the trades on record add up to 11 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 12 June 2024: a share grant, in KALA BIO, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark S. Blumenkranz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
1,400 shares0Common StockSEC:0001415889-24-016569:0
32,088 sharesCommon StockSEC:0001104659-23-080692:0
3,784 shares0Common StockSEC:0001415889-23-010282:0
3 sharesCommon StockSEC:0001415889-23-009139:0
14,588 sharesCommon StockSEC:0001410939-23-000078:0
4,534 shares@ US$18.00100.0% of flowCommon StockSEC:0001562180-23-001846:0
5,000 shares0Common StockSEC:0001410939-22-000084:0
4,534 sharesCommon StockSEC:0001562180-22-004856:0
7,500 sharesCommon StockSEC:0001410939-22-000067:0
157,765 sharesCommon StockSEC:0001415889-21-005278:0
5,000 sharesCommon StockSEC:0001104659-21-093460:0
11 of 11 declarations
